| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/30/2008 | CA2190509C Hepatocyte-selective oil-in-water emulsion |
| 09/25/2008 | WO2008115511A1 Method for therapeutic administration of radionucleosides |
| 09/25/2008 | WO2008115337A1 Sulfur-protected mercaptoacetylglycylglycylglycine |
| 09/25/2008 | WO2008113792A2 Production of thorium 228 starting from a natural thorium salt |
| 09/25/2008 | WO2008073828A3 Compositions and methods for magnetic resonance imaging contrast agents |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233047 Symmetric and Asymmetric Halogen-Containing Metallocarboranylporphyrins and Uses Thereof |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | CA2681180A1 Production of thorium 228 starting from a natural thorium salt |
| 09/24/2008 | EP1971372A2 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 09/24/2008 | EP1809615A4 Lamotrigine analogs |
| 09/24/2008 | CN101272810A A radioactive surface source and a method for producing the same |
| 09/24/2008 | CN101272809A Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 09/23/2008 | US7427671 DNA sequence which code human platelet derived growth factor receptor proteins which preferentially binds to dimers of platelet derived growth factors with high receptivity |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427607 fluidization and spraying powders with gases using microtubes, to target sites: hemostatic agents; preventing biological adhesions and wound healing agents |
| 09/23/2008 | US7427390 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 09/23/2008 | US7427389 halogenated xanthene derivatives such as 4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein, used for imaging human and animal tissues; tomography |
| 09/18/2008 | WO2008112224A2 High radioactivity thallium solutions and uses thereof |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2007143701A3 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 09/18/2008 | US20080228284 Specific Polyphosphazene-Containing Three-Dimensional Bone Support Implants and Methods for Their Use |
| 09/18/2008 | US20080228004 Ligand Protection for Mercaptoacetyl Triglycine |
| 09/18/2008 | US20080227961 Chelation compounds, radionuclides |
| 09/18/2008 | US20080227721 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080226656 RG1 antibodies and uses thereof |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226552 Automated Radiolabelling Method |
| 09/18/2008 | US20080226551 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 09/18/2008 | US20080226550 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 09/18/2008 | US20080226549 Diagnosing cancer; measuring antibody inhibition; calibration; reduced concentration of inhibitor indicates cancer receptivity |
| 09/18/2008 | US20080226548 Methods of Applying Ionization Radiation for Therapy of Hiv Infection |
| 09/18/2008 | US20080226547 Anticancer agents, antitumor agents |
| 09/18/2008 | US20080226546 Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679050A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/17/2008 | EP1968964A1 Radicicol derivatives useful for positron emission tomography |
| 09/17/2008 | EP1968651A2 Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters |
| 09/17/2008 | EP1968650A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 09/17/2008 | EP1968648A2 Diagnostic system for the detection and diagnosis of skin cancer |
| 09/17/2008 | EP1588162B1 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 09/17/2008 | EP1003854B1 Antimicrobial peptides derived from ubiquicidine |
| 09/17/2008 | CN101264325A RS7 antibodies |
| 09/17/2008 | CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20. |
| 09/17/2008 | CN100418585C Stable radiopharmaceutical compositions and methods for preparation |
| 09/16/2008 | US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/16/2008 | US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | CA2358498C The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/12/2008 | WO2008109397A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/12/2008 | WO2008109080A2 Nucleoside based proliferation imaging markers |
| 09/12/2008 | WO2008108311A1 Ge ADSORBENT |
| 09/12/2008 | WO2008107471A2 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 09/12/2008 | WO2008058192A3 Heterodimers of glutamic acid |
| 09/12/2008 | WO2007146595A3 Compositions and methods for diagnosis of axial pain with or without radiculopathy |
| 09/12/2008 | CA2679960A1 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 09/11/2008 | US20080221309 MN Gene and Protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219923 Method and Kit for the Production of Particles Labelled with Rhenium-188 |
| 09/11/2008 | US20080219922 Alzheimer's Disease Imaging Agents |
| 09/11/2008 | US20080219921 Novel Technetium and Rhenium Complexes. |
| 09/11/2008 | US20080219920 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 09/11/2008 | US20080219919 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967517A1 Probe for diagnosis of conformational disease |
| 09/10/2008 | EP1729822A4 Particulate materials and compositions for radio therapy |
| 09/10/2008 | EP1658099B1 Compounds and kits for preparing imaging agents and methods of imaging |
| 09/10/2008 | EP1289570B1 Liposomal encapsulation of alpha-emitters and uses thereof |
| 09/10/2008 | CN101262891A Measurement of gastric acid secretion |
| 09/10/2008 | CN101260147A Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 09/10/2008 | CN101259290A Preparation and application of target tumor intervention therapeutic agent |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN100417421C Organic metal carborane target formulation and its preparation method |
| 09/09/2008 | US7422861 Oligonucleotide transfection screening method |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/04/2008 | WO2008105473A1 Anti-malignant-tumor agent |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2007149453A3 Methods of making and using rubidium-81-containing compositions |
| 09/04/2008 | US20080215138 Coated implantable medical device |
| 09/04/2008 | US20080214853 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 09/04/2008 | US20080214851 Synthesis of labeled fatty acid analogs for use in tomography |
| 09/04/2008 | US20080213188 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/04/2008 | US20080213178 Using a radiolabeled fatty acid analog such as endo-[18F] fluoro- or [123I]iodo-3,4-cyclopropylheptadecanoic acid localized in tissue of interest, imaging, determining blood flow rate |
| 09/04/2008 | US20080213177 Nanoparticles Comprising Rna Ligands |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | US20080213175 Radiolables with amide bond by a 1,4-disubstituted 1,2,3-triazole ("1,2,3-anti-triazole") preserves the cyclic peptides' functional and structural integrity while providing enhanced metabolic stability in vivo |
| 09/04/2008 | US20080213174 Radiolabelled Insulin |
| 09/04/2008 | US20080213173 Labeled fatty acid analogs; tissue-targeted therapy; tomography; block the catabolic pathway, thus trapping these analogs in a virtually unmodified form in the tissues of interest such as heart, liver, or tumor; endo-vinylic variants of cycloalkyl-substituted heptadecanoic acid for example |
| 09/04/2008 | US20080213172 Radioimaging moieties coupled to peptidease-binding moieties for imaging tissues and organs that express peptidases |
| 09/04/2008 | US20080213171 Cancerous disease modifying antibodies |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 09/04/2008 | US20080213168 Use of cd23 antagonists for the treatment of neoplastic disorders |